{"database": "lobbying", "table": "lobbying_activities", "rows": [[3009245, "17304f11-a333-4519-b9e9-74e57c94f487", "Q2", "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", 29403, "CONSUMER HEALTHCARE PRODUCTS ASSOCIATION", 2023, "second_quarter", "PHA", "OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act -- not yet introduced. FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 171093, null, 0, 0, "2023-07-18T10:17:34-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3009245"], "units": {}, "query_ms": 0.6153779104351997, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}